Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Advance ZincTek Limited ( (AU:ANO) ) is now available.
Advance ZincTek Limited has assessed the recent US announcement of 100% tariffs on certain Australian pharmaceuticals and believes its zinc oxide products will not be affected. The products are classified as APIs, not branded or patented, and have historically been excluded from similar tariffs. The company maintains a strategic inventory in the US, ensuring no immediate operational impact. It is monitoring diplomatic discussions and does not foresee any significant financial impact for FY25.
The most recent analyst rating on (AU:ANO) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Advance ZincTek Limited stock, see the AU:ANO Stock Forecast page.
More about Advance ZincTek Limited
Advance ZincTek Limited operates in the pharmaceutical industry, focusing on the production of zinc oxide products which serve as active pharmaceutical ingredients (APIs). The company is not involved in branded or patented pharmaceuticals, which positions it uniquely in the market.
Average Trading Volume: 8,428
Technical Sentiment Signal: Buy
Current Market Cap: A$62.65M
See more insights into ANO stock on TipRanks’ Stock Analysis page.